Chirality of penicilamineWALSHE, J. M.Lancet (British edition). 1992, Vol 339, Num 8787, issn 0140-6736, p. 254Article

Les complications hépatiques de la D. pénicillamine = Hepatic toxicity of the D-penicillaminROUX, H; BONNEFOY-CUDRAZ, M; ANTIPOFF, G. M et al.Rhumatologie (Aix-les-Bains). 1984, Vol 36, Num 7, pp 233-238, issn 0249-7581Article

SUPPRESSION OF ADJUVANT ARTHRITIS BY PENICILLAMINE IN PYRIDOXINE DEFICIENT RATS = INHIBITION DE L'ARTHRITE DE L'ADJUVANT PAR LA PENICILLAMINE CHEZ LES RATS CARENCES EN PYRIDOXINEBAUMGARTNER R; OBENAUS H; STOERK HC et al.1974; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1974; VOL. 146; NO 1; PP. 241-244; BIBL. 13REF.Article

Flow injection analysis and batch procedures for the routine determination of N-penicillamineVINAS, P; SANCHEZ-PRIETO, J. A; HERNANDEZ CORDOBA, M et al.Microchemical journal. 1990, Vol 41, Num 1, pp 2-9, issn 0026-265XArticle

Réactions fébriles à la D-pénicillamine = Febrile reactions to D-penicillamineSEROR, P; BLOTMAN, F; SIMON, L et al.La Semaine des hôpitaux de Paris. 1984, Vol 60, Num 11, pp 784-785, issn 0037-1777Article

The relationship between aurothioglucose: and D-penicillamine-induced proteinuriaSPEERSTRA, F; VAN DE PUTTE, L. B. A; RASKER, J. J et al.Scandinavian journal of rheumatology. 1984, Vol 13, Num 4, pp 363-368, issn 0300-9742Article

Development and evaluation of enteric-coated penicillamine tabletsCHAMBLISS, W. G; CHAMBLISS, D. A; CLEARY, R. W et al.Journal of pharmaceutical sciences. 1984, Vol 73, Num 9, pp 1215-1219, issn 0022-3549Article

Manifestations cutanées observées au cours des traitements par la pénicillamine et ses dérivés = Cutaneous lesions during treatment with penicillamine and penicillamine derivativesVENENCIE, P. Y; MOREL, P.Annales de médecine interne (Paris). 1984, Vol 135, Num 8, pp 642-645, issn 0003-410XArticle

THE INTERACTION OF ADRENOCHROME WITH SOME THIOL-CONTAINING AMINO ACIDS. ISOLATION OF SOME PRODUCTSPOWELL WS; HEACOCK RA.1973; BIOORG. CHEM.; U.S.A.; DA. 1973; VOL. 2; NO 3; PP. 191-196; BIBL. 24 REF.Serial Issue

Les atteintes musculaires d'origine médicamenteuse = Drug-induced myopathiesSERRATRICE, G; DESNUELLE, C; CROS, D et al.Thérapie (Paris). 1984, Vol 39, Num 6, pp 677-687, issn 0040-5957Article

Does drug therapy slow radiographic deterioration in rheumatoid arthritis?IANNUZZI, L; DAWSON, N; ZEIN, N et al.The New England journal of medicine. 1983, Vol 309, Num 17, pp 1023-1028, issn 0028-4793Article

D-penicillamine-induced myasthenia gravis in primary biliary cirrhosisMARCUS, S. N; CHADWICK, D; WALKER, R. J et al.Gastroenterology (New York, NY. 1943). 1984, Vol 86, Num 1, pp 166-168, issn 0016-5085Article

A study of the glutathione metaboloma peptides by energy-resolved mass spectrometry as a tool to investigate into the interference of toxic heavy metals with their metabolic processesRUBINO, Federico Maria; PITTON, Marco; BRAMBILLA, Gabri et al.Journal of mass spectrometry. 2006, Vol 41, Num 12, pp 1578-1593, issn 1076-5174, 16 p.Conference Paper

A new simple and sensitive spectrophotometric method for determination of penicillamine by reaction with nitrite and Co(II) ionsAMIR BESADA.Analytical letters. 1988, Vol 21, Num 3, pp 435-446, issn 0003-2719Article

D-penicillamine withdrawal in rheumatoid arthritisAHERN, M. J; HALL, N. D; CASE, K et al.Annals of the rheumatic diseases. 1984, Vol 43, Num 2, pp 213-217, issn 0003-4967Article

Polymyosite induite par la D-pénicillamine = D-penicillamine induced polymyositisRENIER, J. C; MASSON, C; AUDRAN, M et al.Thérapie (Paris). 1984, Vol 39, Num 6, pp 697-703, issn 0040-5957Article

Eosinophilia in D-penicillamine therapySMITH, D. H; SCOTT, D. L; ZAPHIROPOULOS, G. C et al.Annals of the rheumatic diseases. 1983, Vol 42, Num 4, pp 408-410, issn 0003-4967Article

Preparation of some novel S-nitroso compounds as potential slow-release agents of nitric oxide in vivoMOYNIHAN, H. A; ROBERTS, S. M.Journal of the Chemical Society. Perkin transactions. I. 1994, Num 7, pp 797-805, issn 0300-922XArticle

Eine neue Synthese für ¹⁴C-markiertes Penicillamin = Une nouvelle synthèse de la D-penicillamine marqué au c¹⁴. voie effective pour la synthèse de la D-Penicillamine marquée au C₁₄ = A new systhesis of ¹⁴C-labelled D-Penicillamine. An effective route for the systhesis of 14C-labelled D-Penicillamine is reportedSAUS, A; SCHERBERICH, P.Arzneimittel-Forschung. 1985, Vol 35, Num 4, pp 663-666, issn 0004-4172Article

Interaktionen zwischen Radiophamaka und therapeutika = Interaction entre les produits radioisotiques et les médicaments = Interactions between radiopharmaceuticals and therapeutic drugsVAN DE FLIERDT, E; STUMPF, E; BÖGL, W et al.Nuclear-Medizin. 1985, Vol 24, Num 2, pp 82-86, issn 0029-5566Article

Treatment of hemophilic arthritis with D-penicillamine: a preliminary reportCORRIGAN, J. J. JR; KOLBA, K. S; GALL, E. P et al.American journal of hematology. 1985, Vol 19, Num 3, pp 255-264, issn 0361-8609Article

Effect of D-penicillamine on human granuloporesis in vitroAYMARD, J. P; HERBEUVAL, M; NETTER, P et al.Scandinavian journal of haematology. 1985, Vol 34, Num 3, pp 219-222, issn 0036-553XArticle

La myasthénie au cours du traitement de la polyarthrite rhumatoïde par la D-pénicillamine = D-penicillamine-induced myasthenia gravis in rheumatoid arthritisCARTER, H; JOB-DESLANDRE, C; DELRIEU, F et al.Thérapie (Paris). 1984, Vol 39, Num 6, pp 689-695, issn 0040-5957Article

Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic featuresDELAMERE, J. P; JOBSON, S; MACKINTOSH, L. P et al.Annals of the rheumatic diseases. 1983, Vol 42, Num 5, pp 500-504, issn 0003-4967Article

BIOLOGICALLY ORIENTED ORGANIC SULFUR CHEMISTRY. XXI: HYDRODISULFIDE OF A PENICILLAMINE DERIVATIVE AND RELATED COMPOUNDSHEIMER NE; FIELD L; NEAL RA et al.1981; J. ORG. CHEM.; ISSN 0022-3263; USA; DA. 1981; VOL. 46; NO 7; PP. 1374-1377; BIBL. 12 REF.Article